Tuyển tập báo cáo các nghiên cứu khoa học quốc tế ngành hóa học dành cho các bạn yêu hóa học tham khảo đề tài: Immuno-Oncology Biomarkers 2010 and Beyond: Perspectives from the iSBTc/SITC Biomarker Task Force | H JOURNAL OF TRANSLATIONAL MEDICINE Society for Immunotherapy of Cancer formerly the International Society for Biological Therapy of Cancer Symposium Summary September 30 2010 - National Institutes of Health Bethesda MD Immuno-Oncology Biomarkers 2010 and Beyond Perspectives from the iSBTc SITC Biomarker Task Force Interaction Innovation Integration Exchange Translation Leadership _Guiding cancer immunotherapy from bench to bedside_ Immuno-Oncology biomarkers 2010 and beyond Perspectives from the iSBTc SITC biomarker task force Butterfield et al. Butterfield et al. Journal of Translational Medicine 2010 8 130 http content 8 1 130 7 December 2010 2 BioMed Central Butterfield et al. Journal of Translational Medicine 2010 8 130 http content 8 1 130 TRANSLATIONAL MEDICINE COMMENTARY Open Access Immuno-Oncology biomarkers 2010 and beyond Perspectives from the iSBTc SITC biomarker task force I 11 I_I Di I - ZA rp ZA I zl 1 l A -A n I I ì I r I r 2 c -A ZZA I z I w I I ZA I f3 I -A zz r r l Dill ỊI r4 c z z-ZA r r l A l A -A z I Z-Z A I -A 5 Lisa H Butterfield Mary L Disis Samir N Miieif James M Balwit Francesco M Marincoia Abstract The International Society for Biological Therapy of Cancer ISBTc recently renamed the Society for Immunotherapy of Cancer SITC hosted a one-day symposium at the National Institutes of Health on September 30 2010 to address development and application of biomarkers in cancer immunotherapy. The symposium titled ImmunoOncology Biomarkers 2010 and Beyond Perspectives from the iSBTc SITC Biomarker Task Force gathered approximately 230 investigators equally from academia industry and governmental regulatory agencies from around the globe for panel discussions and presentations on the following topics 1 immunologic monitoring standardization and validation of assays 2 correlation of immunity to biologic activity clinical response and potency assays 3 novel methodologies for
